Enzyme replacement in advanced pancreatic cancer: patient perceptions
Authors:
- 22 March 2020
- journal article
- research article
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (e1) , e122-e128
Abstract
Purpose Advanced pancreatic cancer has a universally poor survival rate. Patients frequently develop malabsorption that requires pancreatic enzyme replacement therapy (PERT). This study explores the experience of patient engagement with PERT and how the medication is taken and tolerated. Methods Participants with advanced pancreatic cancer requiring PERT were interviewed after referral to a specialist palliative care team. An inductive analysis was used to code the data. Theoretical sufficiency was reached after 12 participants. Results Four themes emerged from the interviews-patient context, health literacy, relationship to food and experience of taking the pancreatic enzymes. Respondents brought their own life experiences into the clinical encounter when told of the diagnosis. Patients had high levels of understanding and engagement with the diagnosis and treatment, understood the benefits of PERT in digestion and tolerated the medication well. Conclusions Patients with metastatic pancreatic cancer understand the life-limiting nature of their illness. They want to participate in their healthcare decisions and are capable of complex medication titration when given good explanations and they experience benefits. PERT should be offered to these patients by a team of knowledgeable health professionals with good communication skills that can continue to support and review their needs.Keywords
Funding Information
- Division of Health Sciences, University of Otago
This publication has 25 references indexed in Scilit:
- ‘One also needs a bit of trust in the doctor … ’: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-makingAnnals of Oncology, 2013
- Pancreatic cancer and supportive care—pancreatic exocrine insufficiency negatively impacts on quality of lifeSupportive Care in Cancer, 2013
- The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European SurveyJournal of Gastrointestinal Surgery, 2012
- Physician Communication and Patient Adherence to TreatmentMedical Care, 2009
- Exocrine Function Following the Whipple Operation as Assessed by Stool ElastaseJournal of Gastrointestinal Surgery, 2006
- Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancerClinical Nutrition, 2004
- A New Palliative Prognostic ScoreJournal of Pain and Symptom Management, 1999
- Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancerBritish Journal of Surgery, 1997
- Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic CancerAnnals of Surgery, 1994
- Intestinal Activities of Trypsin, Lipase, and Phospholipase after a Test MealScandinavian Journal of Gastroenterology, 1977